Penn State Health offers leading-edge research and expertise in the diagnosis and
management of conditions involving the urinary tract.
Learn about our latest clinical trials for bladder cancer:
• Chemoablative Gel - Offering a nonsurgical option for destroying bladder
tumors in patients with low-grade, non-muscle-invasive bladder cancer.
• New Hematuria Urine Test - Could replace the full work-up for some
lower-risk patients with blood in the urine.
Now enrolling patients and accepting referrals, call 717-531-8887.
Visit studyfinder.psu.edu for more clinical trials at Penn State Health.
Find out more about Penn State Health Urology in the online edition of the
Urology Update at MedicalUpdate.PennStateHealth.org/Urology.
SRG-15330-20 3 040721
Nationally Recognized
Expertise and Discovery
for Urologic Cancers
pennstatehealth.org/urology
